Vanguard Group’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-221,371
Closed -$4.07M 4361
2020
Q4
$4.07M Buy
221,371
+5,115
+2% +$94K ﹤0.01% 3449
2020
Q3
$3.97M Sell
216,256
-1,038
-0.5% -$19K ﹤0.01% 3268
2020
Q2
$3.25M Buy
217,294
+6,685
+3% +$100K ﹤0.01% 3279
2020
Q1
$3.33M Buy
210,609
+234
+0.1% +$3.7K ﹤0.01% 3148
2019
Q4
$3.42M Sell
210,375
-2,042
-1% -$33.2K ﹤0.01% 3294
2019
Q3
$3.16M Buy
212,417
+1,245
+0.6% +$18.5K ﹤0.01% 3287
2019
Q2
$3.49M Sell
211,172
-3,461
-2% -$57.2K ﹤0.01% 3293
2019
Q1
$3.71M Buy
214,633
+21,152
+11% +$366K ﹤0.01% 3247
2018
Q4
$3.42M Buy
193,481
+9,653
+5% +$170K ﹤0.01% 3212
2018
Q3
$3.34M Buy
183,828
+7,443
+4% +$135K ﹤0.01% 3369
2018
Q2
$3.45M Buy
176,385
+34,352
+24% +$672K ﹤0.01% 3338
2018
Q1
$2.49M Buy
142,033
+58,962
+71% +$1.03M ﹤0.01% 3383
2017
Q4
$943K Hold
83,071
﹤0.01% 3624
2017
Q3
$885K Sell
83,071
-6,480
-7% -$69K ﹤0.01% 3617
2017
Q2
$783K Sell
89,551
-30,059
-25% -$263K ﹤0.01% 3629
2017
Q1
$1.41M Buy
119,610
+228
+0.2% +$2.69K ﹤0.01% 3488
2016
Q4
$1.56M Buy
119,382
+10,359
+10% +$136K ﹤0.01% 3445
2016
Q3
$1.58M Buy
109,023
+5,608
+5% +$81.3K ﹤0.01% 3460
2016
Q2
$1.24M Buy
103,415
+1,541
+2% +$18.5K ﹤0.01% 3541
2016
Q1
$1.9M Buy
101,874
+28,520
+39% +$532K ﹤0.01% 3401
2015
Q4
$1.58M Buy
73,354
+12,978
+21% +$279K ﹤0.01% 3485
2015
Q3
$1.02M Buy
60,376
+23,941
+66% +$405K ﹤0.01% 3624
2015
Q2
$1.37M Buy
36,435
+27,824
+323% +$1.04M ﹤0.01% 3563
2015
Q1
$271K Buy
+8,611
New +$271K ﹤0.01% 3949